Literature DB >> 7956205

Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources.

K M Newman1, A M Malon, R D Shin, J V Scholes, W G Ramey, M D Tilson.   

Abstract

One of the most consistent observations in abdominal aortic aneurysm (AAA) disease is the disorganization and disruption of elastin and other matrix components of the aortic wall. The enzymatic basis for the biochemical features of AAA has been investigated beginning with the demonstration on substrate gel enzymography of a typical "profile" of proteinase activities in AAA tissue extracts which degrade gelatin, casein and elastin. A recombinant TIMP-1 affinity column was developed and three of the elastolytic/caseinolytic activities with approximate molecular weights of approximately 80 kDa, approximately 50 kDa and approximately 32 kDa were partially purified from these extracts. Affinity for rTIMP-1 suggests that these enzymes are members of the matrix metalloproteinase (MMP) family. High molecular weight forms of two MMPs, collagenase (MMP-1) and stromelysin-1 (MMP-3), were also isolated from the AAA tissue on this column; active forms of MMP-1 could be demonstrated by immunoblotting techniques in this preparation under reducing conditions. Infiltrating inflammatory cells are known sources of these proteolytic activities; analysis of these cell populations in the aneurysmal aortic wall using fluorescence-activated cell counting revealed a fifty-fold increase in macrophages (a well-known source of matrix-degrading enzymes) as well as a significant increase in lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956205     DOI: 10.3109/03008209409015042

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  22 in total

1.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas.

Authors:  Koichi Shimizu; Masayoshi Shichiri; Peter Libby; Richard T Lee; Richard N Mitchell
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 2.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

3.  Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese.

Authors:  Naoki Unno; Toshio Nakamura; Hiroshi Mitsuoka; Takashi Uchiyama; Naoto Yamamoto; Takaaki Saito; Junko Sugatani; Masao Miwa; Satoshi Nakamura
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

Review 4.  Clinical potential of matrix metalloprotease inhibitors in cancer therapy.

Authors:  E I Heath; L B Grochow
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 5.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

6.  Upregulation of protein kinase cdelta in vascular smooth muscle cells promotes inflammation in abdominal aortic aneurysm.

Authors:  Sebastian Schubl; Shirling Tsai; Evan J Ryer; Chunjie Wang; June Hu; K Craig Kent; Bo Liu
Journal:  J Surg Res       Date:  2008-05-13       Impact factor: 2.192

7.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

Authors:  G Matthew Longo; Wanfen Xiong; Timothy C Greiner; Yong Zhao; Nicola Fiotti; B Timothy Baxter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone.

Authors:  Nesligul Yildirim; Ishak Ozel Tekin; Mehmet Arasli; Mustafa Aydin
Journal:  Mediators Inflamm       Date:  2010-06-14       Impact factor: 4.711

Review 9.  Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.

Authors:  Faisal Aziz; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2007-05       Impact factor: 1.466

10.  Autoimmunity in the Abdominal Aortic Aneurysm and its Association with Smoking.

Authors:  M David Tilson
Journal:  Aorta (Stamford)       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.